In AD transgenic models in which ADAM10 is over-expressed, β-secretase mediated processing of APP decreases, amyloid plaque formation is lessened, and the cognitive capacities of the dual transgenic animals is improved [55]. The gene discussed is APP; the disease is amyloidosis.